Priming the antimalarial pipeline

David A. Fidock
Additional contact information
David A. Fidock: Columbia University Medical Center, New York, New York 10032, USA. df2260@columbia.edu

Nature, 2010, vol. 465, issue 7296, 297-298

Abstract: Emerging resistance to existing antimalarial drugs could nullify efforts to eliminate this deadly disease. The discovery of thousands of agents active against malaria parasites offers hope for developing new drugs.

Date: 2010
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/465297a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:465:y:2010:i:7296:d:10.1038_465297a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/465297a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().